← Back to patent-cliff list

Vornorexant

Tier C — Watch / trade

Vornorexant

-
Originator
2025
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:OX2R, OX1R

Brand:Vorzzz, ボルズィ

Indications (approved):Insomnia and sleep disorders

Regional status

US
No progress
2020-09-14
EU
-
China
-
Japan
Approved
2025-08-25

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 9 · Total yield /
Vornorexant-001156-87-6Vornorexant-002298-12-4Vornorexant-003—Vornorexant-004501-53-1Vornorexant-005—Vornorexant-0062549-14-6Vornorexant-007—Vornorexant-008—Vornorexant-009—Vornorexant-010—Vornorexant-0111104546-96-4Vornorexant-012—Vornorexant-013—Vornorexant-014—Vornorexant-015449758-17-2Vornorexant-01631301-51-6Vornorexant-0171381971-84-1Vornorexant-0181382035-54-2Vornorexant-019956317-36-5API · Vornorexant
CodeCAS No.Intermediate
Vornorexant-001156-87-63-aminopropan-1-ol
Vornorexant-002298-12-4Available2-oxoacetic acid
Vornorexant-003-1,3-oxazinane-2-carboxylic acid
Vornorexant-004501-53-1Availablebenzyl carbonochloridate
Vornorexant-005-3-((benzyloxy)carbonyl)-1,3-oxazinane-2-carboxylic acid
Vornorexant-0062549-14-6(R)-2-amino-2-phenylethan-1-ol
Vornorexant-007-(S)-3-((benzyloxy)carbonyl)-1,3-oxazinane-2-carboxylic acid, (R)-2-amino-2-phenylethan-1-ol
Vornorexant-008-(S)-3-((benzyloxy)carbonyl)-1,3-oxazinane-2-carboxylic acid
Vornorexant-009-3-benzyl 2-methyl (S)-1,3-oxazinane-2,3-dicarboxylate
Vornorexant-010-methyl (S)-1,3-oxazinane-2-carboxylate
Vornorexant-0111104546-96-45-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl chloride
Vornorexant-012-methyl (S)-3-(5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl)-1,3-oxazinane-2-carboxylate
Vornorexant-013-(S)-(2-(hydroxymethyl)-1,3-oxazinan-3-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
Vornorexant-014-5-fluoro-2-(1-(methylsulfonyl)-1H-pyrazol-3-yl)pyridine
Vornorexant-015449758-17-21-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole
Vornorexant-01631301-51-62-chloro-5-fluoropyridine
Vornorexant-0171381971-84-15-fluoro-2-(1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)pyridine
Vornorexant-0181382035-54-25-fluoro-2-(1H-pyrazol-3-yl)pyridine
Vornorexant-019956317-36-5Available5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid

Frequently asked questions

What are the approved indications of Vornorexant?

Approved indications include: Insomnia and sleep disorders.

When does the Vornorexant patent expire?

No public expiry year is available for Vornorexant yet; this page updates once verified.

How many synthesis routes are recorded for Vornorexant?

1 synthesis routes are recorded; the shortest is 9 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Vornorexant intermediates?

3 intermediate CAS of Vornorexant are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Vornorexant intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-22